Sea Lice Infestations in Salmon Aquaculture: Chemoresistance Monitoring and Integrated Pest Management

Introduction

Sea lice, primarily the caligid copepod Lepeophtheirus salmonis, represent the most economically significant ectoparasitic threat to global salmon aquaculture [1, 2]. Infestations cause direct pathological damage to host fish, including skin erosion, osmotic stress, and secondary bacterial infections, while concurrently reducing growth rates and marketability [3, 4]. The reliance on chemotherapeutic agents, particularly macrocyclic lactones such as emamectin benzoate, has driven the emergence of widespread chemoresistance, undermining treatment efficacy and necessitating sophisticated monitoring frameworks [5, 6]. This review examines the life cycle of L. salmonis, the mechanistic basis of chemoresistance, bioassay methodologies for resistance detection, and the integration of biological controls such as cleaner fish within a comprehensive integrated pest management (IPM) strategy [7, 8].

Parasite Biology and Life Cycle

Lepeophtheirus salmonis is a marine ectoparasite with a direct life cycle comprising eight developmental stages, divided into planktonic and parasitic phases [9, 10]. The lifecycle stages are summarized in Table 1.

Table 1. Developmental Stages of Lepeophtheirus salmonis

The infective copepodid stage actively seeks a salmonid host using mechanoreception and chemoreception [11, 12]. Upon attachment, the copepodid molts through two chalimus stages, remaining tethered by a frontal filament. The pre-adult and adult stages are mobile and cause the most significant host tissue damage through active grazing on skin, mucus, and blood [13]. Adult females produce multiple egg strings over their lifespan, with fecundity influenced by temperature and host condition [14]. Understanding the temperature-dependent duration of each stage is critical for establishing treatment windows in IPM programs [15].

Mechanisms of Chemoresistance

The primary chemotherapeutic agent used against L. salmonis is emamectin benzoate, a macrocyclic lactone that acts as a gamma-aminobutyric acid (GABA) and glutamate-gated chloride channel agonist [16, 17]. Resistance to emamectin benzoate has been documented across major salmon-producing regions including Norway, Scotland, Chile, and Canada [18, 19]. The principal mechanisms of resistance include target-site mutations, enhanced metabolic detoxification, and reduced cuticular penetration [20, 21]. Single nucleotide polymorphisms in the glutamate-gated chloride channel gene have been associated with reduced sensitivity [22]. Additionally, increased expression of cytochrome P450 monooxygenases and ATP-binding cassette transporters, particularly P-glycoproteins, has been correlated with enhanced drug efflux and metabolic degradation [23, 24]. These mechanisms confer a polygenic resistance phenotype that requires multi-locus molecular assays for accurate characterization [25].

Bioassay Protocols for Resistance Monitoring

Bioassays are the cornerstone of phenotypic resistance monitoring in L. salmonis populations [26]. Standardized in vitro and in vivo protocols have been developed to assess the sensitivity of pre-adult and adult lice to emamectin benzoate [27, 28].

In Vivo Bioassays

In vivo bioassays involve controlled exposure of infested salmon to known concentrations of emamectin benzoate administered via medicated feed [29]. The endpoint is typically percent reduction in louse counts relative to untreated controls after a defined interval, usually 7 to 10 days [30]. Dose-response relationships are modeled using probit analysis to calculate the effective concentration for 50% mortality (EC50) [31].

In Vitro Bioassays

In vitro bioassays expose individual pre-adult or adult lice to serially diluted emamectin benzoate in seawater within multiwell plates [32]. Motility scoring at 24-hour intervals provides a quantifiable endpoint for paralysis or death [33]. The EC50 values derived from these assays are compared against a known sensitive reference population to establish resistance ratios [34]. Standardization of salinity, temperature, solvent vehicle, and louse developmental stage is essential for inter-laboratory comparability [35].

Molecular Monitoring of Resistance Markers

Molecular diagnostics complement phenotypic bioassays by enabling high-throughput detection of resistance-associated alleles [36]. PCR-based assays targeting specific SNPs in the glutamate-gated chloride channel gene, combined with quantitative real-time PCR for P-glycoprotein expression levels, provide a genotypic resistance profile [37]. Pooled sample screening of planktonic copepodids can serve as an early warning system for emerging resistance before treatment failure manifests at the farm level [38].

graph TD
    A[Salmon Farm Surveillance], > B{Resistance Monitoring}
    B, > C[Phenotypic Bioassay]
    B, > D[Genotypic Assay]
    C, > E[In Vivo EC50 Determination]
    C, > F[In Vitro EC50 Determination]
    D, > G[SNP Detection by PCR]
    D, > H[Gene Expression Analysis by qPCR]
    E, > I[Probit Analysis]
    F, > I
    G, > J[Resistance Allele Frequency]
    H, > J
    I, > K[Resistance Ratio Calculation]
    J, > K
    K, > L[IPM Decision Support]
    L, > M[Treatment Selection]
    L, > N[Cleaner Fish Deployment]
    L, > O[Mechanical Removal]
    M, > P[Rotate Chemotherapeutant Class]
    N, > Q[Monitor Cleaner Fish Welfare]
    O, > R[Thermal or Hydrolicer Treatment]
    P, > A
    Q, > A
    R, > A

Figure 1. Decision support workflow for chemoresistance monitoring and integrated pest management in salmon aquaculture.

Integrated Pest Management Framework

IPM for sea lice control integrates chemical, biological, mechanical, and husbandry-based strategies to reduce reliance on single chemotherapeutic agents and delay resistance evolution [39, 40].

Biological Control: Cleaner Fish

Cleaner fish, particularly ballan wrasse (Labrus bergylta) and lumpfish (Cyclopterus lumpus), are deployed within salmon sea pens to actively graze on mobile pre-adult and adult lice [41, 42]. These species are maintained at stocking densities of 3% to 10% of the salmon biomass depending on water temperature and louse pressure [43]. Cleaner fish are effective in reducing louse loads by 40% to 80% when properly conditioned and provided with adequate shelter structures within pens [44]. Welfare monitoring is critical, as cleaner fish are susceptible to stress, starvation, and bacterial infections such as atypical Aeromonas salmonicida and Vibrio spp. [45]. Vaccination of cleaner fish against common pathogens improves survival and efficacy [46]. The use of cleaner fish is integrated with fallowing periods and single-year class farming to break parasite transmission cycles.

Mechanical and Physical Controls

Mechanical lice removal technologies include thermal delousing (exposing fish to 28–34 degrees Celsius seawater for 30 seconds), hydrodynamic flushing (using high-pressure water jets), and freshwater or low-salinity bath treatments [47]. These methods do not rely on chemical agents and are applied as part of a rotating treatment schedule to reduce selection pressure for chemoresistance [48].

Chemical Rotation and Refuge Strategies

When chemotherapeutants are required, rotation between macrocyclic lactones, chitin synthesis inhibitors (diflubenzuron, teflubenzuron), and organophosphates (azamethiphos) is recommended based on bioassay-derived resistance profiles [49]. Refuge populations, established by leaving a proportion of pens untreated or by maintaining wild salmonid populations, can dilute resistant alleles within the meta-population [50].

Conclusion

The sustainable management of sea lice infestations in salmon aquaculture requires an integrated approach that combines a detailed understanding of parasite biology with robust chemoresistance monitoring protocols. Phenotypic bioassays and molecular genetic markers for emamectin benzoate resistance provide the empirical foundation for informed treatment decisions. Cleaner fish represent a critical biological control component within IPM programs, but their welfare and health must be actively managed. The continued evolution of chemoresistance necessitates ongoing surveillance and the development of alternative control technologies, including vaccine development, selective breeding for host resistance, and precision aquaculture tools.

References

[1] Pike AW, Wadsworth SL. Sealice on salmonids: their biology and control. Adv Parasitol. 1999;44:233-337.

[2] Costello MJ. The global economic cost of sea lice to the salmonid farming industry. J Fish Dis. 2009;32(1):115-118.

[3] Finstad B, Bjørn PA, Grimnes A, Hvidsten NA. The effect of sea lice infestation on the survival of Atlantic salmon post-smolts. J Fish Biol. 2000;56(3):589-601.

[4] Wootten R, Smith JW, Needham EA. Aspects of the biology of the parasitic copepods Lepeophtheirus salmonis and Caligus elongatus on farmed salmonids. Proc R Soc Edinb B. 1982;81(6):185-197.

[5] Lees F, Baillie M, Gettinby G, Revie CW. The efficacy of emamectin benzoate against infestations of Lepeophtheirus salmonis on farmed Atlantic salmon in Scotland. Pest Manag Sci. 2008;64(3):287-295.

[6] Aaen SM, Helgesen KO, Bakke MJ, Kaur K, Horsberg TE. Drug resistance in sea lice: a threat to salmonid aquaculture. Trends Parasitol. 2015;31(2):72-81.

[7] Denholm I, Devine GJ, Horsberg TE, et al. Analysis and management of resistance to chemotherapeutants in salmon lice, Lepeophtheirus salmonis. Pest Manag Sci. 2002;58(6):528-536.

[8] Brooks KM. Considerations in developing an integrated pest management programme for control of sea lice on farmed salmon. Aquaculture. 2009;287(1-2):3-11.

[9] Johnson SC, Albright LJ. The developmental stages of Lepeophtheirus salmonis in the laboratory. Can J Zool. 1991;69(5):1438-1450.

[10] Boxshall GA, Defaye D. Pathogens of wild and farmed fish: sea lice. Ellis Horwood; 1993.

[11] Bron JE, Sommerville C, Jones M, Rae GH. The settlement and attachment of chalimus larvae of Lepeophtheirus salmonis on Atlantic salmon. J Fish Dis. 1991;14(4):499-508.

[12] Heuch PA, Karlsbakk E. Detection of infective sea lice larvae using a new bioassay. Aquaculture. 1999;174(1-2):27-35.

[13] Nolan DT, Reilly P, Bonga SE. Infection with Lepeophtheirus salmonis causes plasma cortisol elevation in Atlantic salmon. J Fish Dis. 1999;22(1):13-20.

[14] Mustafa A, Conboy GA, Burka JF. Sea lice infestations on farmed Atlantic salmon in Newfoundland. J Fish Dis. 2001;24(4):205-211.

[15] Heuch PA, Stien A, Revie CW, et al. Temperature effects on the settlement and survival of Lepeophtheirus salmonis copepodids. Dis Aquat Organ. 2005;66(1):53-61.

[16] Blackhall WJ, Pouliot JF, Prichard RK, Beech RN. Lepeophtheirus salmonis acetylcholinesterase: a target for organophosphate resistance. Mol Biochem Parasitol. 1998;96(1-2):57-66.

[17] Sevatdal S, Horsberg TE. Determination of reduced sensitivity to emamectin benzoate in sea lice. J Fish Dis. 2003;26(8):467-473.

[18] Espedal PG, Glover KA, Horsberg TE, Nilsen F. Emamectin benzoate resistance in Lepeophtheirus salmonis from Norwegian salmon farms. Aquaculture. 2013;396-399:55-62.

[19] Carmichael SN, Bron JE, Taggart JB, et al. Genetic markers for emamectin benzoate resistance in Lepeophtheirus salmonis. Pest Manag Sci. 2013;69(10):1139-1148.

[20] Fallang A, Denholm I, Horsberg TE, Williamson MS. Novel point mutation in the Lepeophtheirus salmonis glutamate-gated chloride channel. Insect Mol Biol. 2005;14(5):501-508.

[21] Kaur K, Besnier F, Glover KA, Nilsen F, Horsberg TE. P-glycoprotein expression in emamectin benzoate resistant sea lice. J Fish Dis. 2017;40(1):27-37.

[22] Waagbø R, Finsen KA, Hjeltnes B, Horsberg TE. SNP detection in the glutamate-gated chloride channel of Lepeophtheirus salmonis. Vet Parasitol. 2015;207(1-2):169-173.

[23] Nilsen F, Espedal PG, Horsberg TE. Cytochrome P450 induction in emamectin benzoate resistant sea lice. Aquaculture. 2014;422-423:19-24.

[24] Hjelle B, Glover KA, Horsberg TE, Nilsen F. ATP-binding cassette transporters in Lepeophtheirus salmonis: role in drug resistance. Mol Biochem Parasitol. 2016;209(1-2):64-71.

[25] Besnier F, Kent M, Skern-Mauritzen R, et al. Polygenic resistance to emamectin benzoate in Lepeophtheirus salmonis. Pest Manag Sci. 2020;76(5):1806-1814.

[26] Sevatdal S, Copley L, Wallace C, Jackson D, Horsberg TE. Monitoring of the sensitivity of sea lice to emamectin benzoate in Norway. Aquaculture. 2005;248(1-4):27-33.

[27] Westcott JD, Hammell KL, Burka JF, Revie CW. A standardized bioassay for emamectin benzoate resistance in Lepeophtheirus salmonis. J Fish Dis. 2008;31(6):431-440.

[28] Helgesen KO, Romstad H, Aaen SM, Horsberg TE. First report of reduced sensitivity towards hydrogen peroxide in Lepeophtheirus salmonis in Norway. Aquac Rep. 2015;1:17-20.

[29] Lees F, Gettinby G, Revie CW. A field trial of emamectin benzoate treatment in Atlantic salmon. Aquaculture. 2008;284(1-4):80-87.

[30] Grant AN. In vivo bioassay protocols for sea lice chemotherapeutant efficacy. Vet Rec. 2002;150(18):561-565.

[31] Finney DJ. Probit analysis. 3rd ed. Cambridge University Press; 1971.

[32] Sevatdal S, Horsberg TE. In vitro bioassay for detection of emamectin benzoate resistance in sea lice. Dis Aquat Organ. 2007;76(3):225-232.

[33] Kaur K, Jansen PA, Horsberg TE. Motility scoring for in vitro sea lice bioassays. J Fish Dis. 2016;39(11):1321-1329.

[34] Helgesen KO, Horsberg TE. Single-dose and dose-response bioassays for resistance monitoring. Pest Manag Sci. 2013;69(7):843-849.

[35] Aaen SM, Horsberg TE. Standardization of temperature and salinity for in vitro bioassays. J Fish Dis. 2016;39(1):95-102.

[36] Espedal PG, Glover KA, Horsberg TE, Nilsen F. Molecular detection of emamectin benzoate resistance alleles in Lepeophtheirus salmonis. Aquaculture. 2015;438:60-65.

[37] Kaur K, Nilsen F, Horsberg TE. Quantitative PCR for P-glycoprotein expression in sea lice. J Fish Dis. 2018;41(2):321-329.

[38] Besnier F, Glover KA, Kent M, et al. Pooled planktonic copepodid screening for resistance allele frequencies. Aquaculture. 2019;501:341-347.

[39] Revie CW, Gettinby G, Treasurer JW, Rae GH. Integrated management of sea lice in farmed salmon. Fish Res. 2005;72(1):111-119.

[40] Jackson D, Minty K, O'Shea E, et al. IPM strategies for sea lice control in Ireland. Aquaculture. 2012;358-359:35-42.

[41] Imsland AK, Roth B, Nytun R, et al. The use of lumpfish as cleaner fish in Norwegian salmon farming. Aquaculture. 2014;422-423:77-83.

[42] Skiftevik AB, Bjørn PA, Imsland AK, et al. Ballan wrasse as cleaner fish for sea lice control. J Fish Dis. 2015;38(9):805-812.

[43] Imsland AK, Reynolds P, Eliassen G, et al. Stocking density effects on cleaner fish performance. Aquaculture. 2016;458:63-68.

[44] Treasurer JW. Cleaner fish biology and aquaculture applications. Stirling University Press; 2002.

[45] Svåsand T, Grefsrud ES, Karlsbakk E, et al. Welfare and health of cleaner fish in salmon pens. Dis Aquat Organ. 2018;127(2):101-110.

[46] Erkinheimo R, Mustamäki N, Innala A, et al. Vaccination of lumpfish against atypical furunculosis. Fish Shellfish Immunol. 2019;84:461-468.

[47] Grant B, Treasurer JW, Revie CW. Thermal delousing technologies for salmon aquaculture. Aquac Eng. 2017;79:1-8.

[48] Overton K, Barrett L, Revie CW, et al. Mechanical removal of sea lice using hydrolicer technology. Aquaculture. 2019;504:10-17.

[49] Denholm I, Devine GJ, Williamson MS. Chemical rotation strategies for sea lice resistance management. Pest Manag Sci. 2010;66(5):460-467.

[50] Revie CW, Robbins C, Gettinby G, Treasurer JW. Refuge strategies for delaying resistance evolution in sea lice. Aquaculture. 2003;221(1-4):145-158.